Interleukin (IL)-6 is one of the most typical tumor-promoting cytokines (49), which can promote the migration and invasion of lung cancer and angiogenesis, and can promote the metastasis of NSCLC through the IL-6-STAT3 pathway (50, 51). This evidence concerns the gene STAT3 and neoplasm.